Network origin in Julian Pei first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 14 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Julian Pei via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| CELGENE | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Ignite Immunotherapy, Inc.
 Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Biotechnology | Founder Founder | |
| University of Oxford | College/University | Corporate Officer/Principal Graduate Degree | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Founder Chief Tech/Sci/R&D Officer | |
| KITE PHARMA INC | Biotechnology | Corporate Officer/Principal | |
| UDG HEALTHCARE PLC | Miscellaneous Commercial Services | Director/Board Member | |
| Murray State University (Kentucky) | College/University | Masters Business Admin | |
| KADMON HOLDINGS, INC. | Biotechnology | Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| ALDEYRA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Altum Pharmaceuticals, Inc.
 Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Altum Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the clinical and commercial development of novel healthcare products for the treatment of women's gynecological neoplasia, autoimmune disorders, Hypercalcemia of Malignancy, Skeletal Related Events and Osteoporosis diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada. | Pharmaceuticals: Generic | Chairman | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| DIPLOMAT PHARMACY, INC. | Drugstore Chains | Director/Board Member | |
| Ithaca College | College/University | Undergraduate Degree | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Director/Board Member | |
| CABALETTA BIO, INC. | Biotechnology | Director/Board Member | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| ALLOVIR, INC. | Biotechnology | Director/Board Member | |
Attralus, Inc.
 Attralus, Inc. Pharmaceuticals: MajorHealth Technology Attralus, Inc. operates as a biopharmaceutical company. The firm focuses on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company was founded by Jonathan Wall in 2019 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Chairman | |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Biotechnology | Director/Board Member | |
| MESOBLAST LIMITED | Biotechnology | Director/Board Member | |
| UROGEN PHARMA LTD. | Biotechnology | Director/Board Member | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Shawn Tomasello Consulting LLC
 Shawn Tomasello Consulting LLC Miscellaneous Commercial ServicesCommercial Services Shawn Tomasello Consulting LLC provides business consulting services. The private company is based in Miramar Beach. The American company was founded by Shawn Cline Tomasello. | Miscellaneous Commercial Services | Chief Executive Officer | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Executive Officer | |
TEN63 Therapeutics
 TEN63 Therapeutics Pharmaceuticals: MajorHealth Technology TEN63 Therapeutics provides drug development services. The American company was founded by Nancy Miller-Rich, Marcel Frenkel, Mark Hallen, Bruce Donald. Marcel Frenkel has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
Proteus Digital Health, Inc.
 Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Corporate Officer/Principal | |
Vision Medicines, Inc.
 Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Viewpoint Therapeutics, Inc.
 Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Haas School of Business | College/University | Masters Business Admin | |
| Brown University | College/University | Doctorate Degree | |
| Tokyo Medical & Dental University | College/University | Graduate Degree | |
| University of Pennsylvania | College/University | Graduate Degree | |
| University of Georgia | College/University | Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | General Counsel | |
Synthego Corp.
 Synthego Corp. BiotechnologyHealth Technology Synthego Corp. provides the game changing by integrating science, engineering and software. It designs and builds software and hardware solutions for building automated smart research facilities. The company was founded Michael Dabrowski and Paul Dabrowski in 2012 and is headquartered in Redwood City, CA. | Biotechnology | General Counsel | |
| Indiana University | College/University | Doctorate Degree | |
Immune-Onc Therapeutics, Inc.
 Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Cincinnati (Ohio) | College/University | Undergraduate Degree |
Statistics
International
| United States | 44 |
| United Kingdom | 3 |
| Canada | 3 |
| Ireland | 2 |
| Australia | 2 |
Sectoral
| Health Technology | 35 |
| Consumer Services | 13 |
| Commercial Services | 4 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 59 |
| Corporate Officer/Principal | 31 |
| Independent Dir/Board Member | 27 |
| Undergraduate Degree | 12 |
| Chief Tech/Sci/R&D Officer | 12 |
Most connected contacts
| Insiders | |
|---|---|
| Shawn Tomasello | 22 |
| Susannah Gray | 20 |
| Jacob Chacko | 18 |
| Nancy Miller-Rich | 15 |
| David Kirn | 14 |
| John Milligan | 9 |
| Charles Theuer | 9 |
| Uneek Mehra | 8 |
| Robert Kim | 7 |
| Theresa Janke | 6 |
| Fariborz Kamal | 6 |
| Scott Bizily | 6 |
| An Song | 3 |
| Noriyuki Kasahara | 3 |
- Stock Market
- Insiders
- Julian Pei
- Company connections
